Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Renew Your AUA Membership!
Your 2026 membership renewal is due December 31, 2025. Complete your renewal by the deadline to avoid a 10% late fee and continue accessing your AUA member benefits in the year ahead.
advertisement
advertisement
Member Advantages
- New AUA ILB Podcast: Exploring Medical Practice Models
- Dr. David Albala joins Dr. Jennifer Miles-Thomas to take a look inside the multidisciplinary group model of medical practice - where physicians, specialists, and allied health professionals collaborate under one roof. Listen Now
- APP of the Year Nominations Now Open
- Nominate an outstanding Advanced Practice Provider (APP) who is making a significant impact in patient care, mentoring colleagues, or demonstrating exceptionl leadership. Apply Now
- Register for the 2026 Annual Review Course
- Tailored for residents and curated for practicing urologists and allied health professionals, this course aims to successfully prepare residents for the ABU exam while offering a comprehensive review of essential urologic topics. Register Now
- New AUANews Inside Tract Podcast: Navigating the Urology Team- The APP-Physician Dynamic
- Dr. Catherine Nam and Dr. Hannah Glick explore key findings from the AUA Census on burnout among urologists, with nearly half reporting symptoms of stress. The episode also offers actionable steps for physicians, administrators, and policymakers to support well-being and shift the culture around mental health in medicine. Listen Now
Upcoming Events
Latest from the Journals
JU | December 2025
In QUILT-3.032, the efficacy of interleukin-15 receptor agonist, nogapendekin alfa inbakicept (NAI), in combination with bacillus Calmette-Guérin (BCG) for BCG-unresponsive high-grade papillary-only nonmuscle-invasive bladder cancer was assessed. In this study, we report the 36-month follow-up among participants with BCG-unresponsive papillary disease (cohort B).
Census By the Numbers
The number of patient encounters in a typical week.
Learn MoreThe percentage of practicing urologists who treat patients with bladder cancer.
Learn MoreNumber of urologists who treat bladder cancer with oncology as a subspecialty reported adapting their practice for BCG shortages.
Learn More